Erratum: ATP11B mediates platinum resistance in ovarian cancer (J Clin Invest (2013) 123:5 (2119-2130) DOI: 10.1172/JCI65425)

Myrthala Moreno-Smith, Gabriel Lopez-Berestein, Anil K. Sood

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

Original citation: J Clin Invest. 2013;123(5):2119-2130. https://doi.org/10.1172/JCI65425 Citation for this expression of concern: J Clin Invest. 2018;128(7):3199. https://doi.org/10.1172/JCI122301 The Editors recently became aware that Figure 3B appears to use a set of images that were previously published in a 2009 Clinical Cancer Research paper with different sample labels (doi: 10.1158/1078-0432.CCR-08-2306). Additionally, the empty liposome and control siRNA PCNA-stained panels appear to be the same. The Editorial Board is pursuing further investigation of this matter, and we will inform our readers of the outcome when the investigation is complete.

Original languageEnglish (US)
Pages (from-to)3199
Number of pages1
JournalJournal of Clinical Investigation
Volume128
Issue number7
DOIs
StatePublished - Jul 2018

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Erratum: ATP11B mediates platinum resistance in ovarian cancer (J Clin Invest (2013) 123:5 (2119-2130) DOI: 10.1172/JCI65425)'. Together they form a unique fingerprint.

Cite this